Le Lézard
Classified in: Health
Subjects: PER, SCZ

Ridgecrest Healthcare Names Charles Seal-Villafranca as Executive Director


PHOENIX, June 3, 2020 /PRNewswire-PRWeb/ -- Ridgecrest Healthcare, a skilled nursing and rehabilitation center located in Phoenix, Arizona, appointed Charles Seal-Villafranca, DHA(c), MSHA, CDP, ALFM-BC, as its new Executive Directory and Administrator. Villafranca assumes all the roles, responsibilities and relationships of Katie Molaro, the outgoing administrator.

Villafranca began his career in healthcare in 1994 and has held various positions in senior living management at the managerial and director levels and is licensed as a Dementia Care Practitioner. He left his previous position as the Executive Director of Encanto Palms Assisted Living, a deficiency-free community in Phoenix, Arizona, to assume the position at Ridgecrest Healthcare.

Villafranca was recently re-elected as the President of the Arizona State Board of Examiners of Nursing Care Institution Administrators and Assisted Living Facility Managers (NCIA). As President of NCIA, Villafranca acts as the chief judge to grant or deny administrator licenses and rules on legal complaints against nursing home administrators and assisted living managers. He also works with the Arizona State government to develop and define state statutes, rules and regulations for nursing homes and assisted living facilities.

"It is an honor to assume the role of Administrator of Ridgecrest Healthcare," says Villafranca. "Over my years at Encanto Palms Assisted Living, I had many opportunities to interact with the amazing staff here and I look forward to enhance and improve the care we provide our residents."

Villafranca received a Master's Degree in Healthcare Administration from the University of St. Francis and is currently a Doctoral Candidate at Capella University for Healthcare Administration. He enjoys working with seniors and is a strong advocate for their needs. He is a devoted husband and proud father of two sons. His professional affiliations include the American College of Healthcare Executives, American College of Healthcare Administrators, and the Arizona Geriatrics Society.

About Ridgecrest Healthcare:
Ridgecrest Healthcare is a 200-bed skilled nursing facility and rehabilitation center associated with Windsor healthcare centers. Windsor provides short-term and long-term healthcare, rehabilitation services and assisted living communities throughout California and Arizona. Windsor employs professionals that provide nursing, therapeutic, sub-acute and rehabilitation care to over 4,000 patients daily.

 

SOURCE Windsor Healthcare


These press releases may also interest you

at 20:05
Bio-Rad Laboratories, Inc. , a global leader of life science research and clinical diagnostic products, will report financial results for the second quarter 2020 on Thursday, July 30, 2020, following the close of the market. The company will discuss...

at 19:32
On behalf of the American BioDefense Institute, we commend Rep. Paul Gosar of Arizona on proposing an amendment to the H.R.6395 - William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021. We submit this statement for the...

at 19:01
In lieu of an in-person update to the media, Dr. Howard Njoo, Canada's Deputy Chief Public Health Officer, issued the following statement on behalf of Dr. Theresa Tam, Canada's Chief Public Health Officer. "There have been 108,486 cases of COVID-19...

at 18:57
Neptune Wellness Solutions Inc. ("NEPT" or the "Company") , a diversified and fully integrated health and wellness company focused on natural, plant-based, sustainable and purpose-driven lifestyle brands, today announced it has closed its...

at 18:26
New projections released today by PolicyLab at Children's Hospital of Philadelphia (CHOP) forecast a continued surge in COVID-19 cases over the next four weeks in many areas of the country, with renewed risk spreading into the Northeast and Midwest,...

at 18:12
Mallinckrodt plc , a global biopharmaceutical company, today announced that the Cardiovascular and Renal Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted to recommend approval for its investigational agent terlipressin to...



News published on 3 june 2020 at 16:50 and distributed by: